Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Pollack

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Cancer Medicine|May 7, 2020
Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United StatesSeth M Pollack, Neeta Somaiah, Dejka M Araujo, et al.
Cancer Investigation|March 15, 2021
Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort AnalysisMichael J Wagner, Seth M Pollack, Lee D Cranmer, et al.
Cancer|February 24, 2012
NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcomaSeth M Pollack, Achim A Jungbluth, Benjamin L Hoch, et al.
Clinical Medicine Insights. Oncology|June 23, 2025
Primary Management of Localized Gastrointestinal Stromal Tumors With Imatinib Monotherapy: An Alternative to Resection of Patients Precluded From SurgeryJohn S Wang, Brandon L Ellsworth, Rusul Al-Marayaty, et al.
Annals of Epidemiology|June 2, 2025
County-level socioeconomic, race-ethnicity, household, and infrastructure vulnerability associations with bone cancer treatment and prognosis in the USDavid J Fei-Zhang, Erik B Gerlach, Shyam Chandrasekar, et al.
Advances in Radiation Oncology|April 24, 2019
MRI Radiomic Features Are Independently Associated With Overall Survival in Soft Tissue SarcomaMatthew B Spraker, Landon S Wootton, Daniel S Hippe, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 14, 2025
Trends and Outcomes for Patients Receiving Neoadjuvant Therapy for Stage I-III Gastric Gastrointestinal Stromal TumorsCade F Bennett, Lauren M Janczewski, Dominic Vitello, et al.
Cancer Immunology Research|June 8, 2019
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical TrialShihong Zhang, Karan Kohli, R Graeme Black, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2022
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and LeiomyosarcomaMichael J Wagner, Yuzheng Zhang, Lee D Cranmer, et al.
BMC Cancer|October 31, 2024
B7-H3 is widely expressed in soft tissue sarcomasMeghan M Lynch, Rusul Al-Marayaty, Farres Obeidin, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Cancer Medicine|May 7, 2020
Clinical outcomes of patients with advanced synovial sarcoma or myxoid/round cell liposarcoma treated at major cancer centers in the United StatesSeth M Pollack, Neeta Somaiah, Dejka M Araujo, et al.
Cancer Investigation|March 15, 2021
Outcomes of Patients with Sarcoma and COVID-19 Infection: A Single Institution Cohort AnalysisMichael J Wagner, Seth M Pollack, Lee D Cranmer, et al.
Cancer|February 24, 2012
NY-ESO-1 is a ubiquitous immunotherapeutic target antigen for patients with myxoid/round cell liposarcomaSeth M Pollack, Achim A Jungbluth, Benjamin L Hoch, et al.
Clinical Medicine Insights. Oncology|June 23, 2025
Primary Management of Localized Gastrointestinal Stromal Tumors With Imatinib Monotherapy: An Alternative to Resection of Patients Precluded From SurgeryJohn S Wang, Brandon L Ellsworth, Rusul Al-Marayaty, et al.
Annals of Epidemiology|June 2, 2025
County-level socioeconomic, race-ethnicity, household, and infrastructure vulnerability associations with bone cancer treatment and prognosis in the USDavid J Fei-Zhang, Erik B Gerlach, Shyam Chandrasekar, et al.
Advances in Radiation Oncology|April 24, 2019
MRI Radiomic Features Are Independently Associated With Overall Survival in Soft Tissue SarcomaMatthew B Spraker, Landon S Wootton, Daniel S Hippe, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|June 14, 2025
Trends and Outcomes for Patients Receiving Neoadjuvant Therapy for Stage I-III Gastric Gastrointestinal Stromal TumorsCade F Bennett, Lauren M Janczewski, Dominic Vitello, et al.
Cancer Immunology Research|June 8, 2019
Systemic Interferon-γ Increases MHC Class I Expression and T-cell Infiltration in Cold Tumors: Results of a Phase 0 Clinical TrialShihong Zhang, Karan Kohli, R Graeme Black, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2022
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and LeiomyosarcomaMichael J Wagner, Yuzheng Zhang, Lee D Cranmer, et al.
BMC Cancer|October 31, 2024
B7-H3 is widely expressed in soft tissue sarcomasMeghan M Lynch, Rusul Al-Marayaty, Farres Obeidin, et al.
Pageof 11